Download DNB 2017 Dec RTH RTH PAPER III Question Paper

Download Diplomate in National Board (DNB) 2017 Dec RTH RTH PAPER III Previous Question Papers

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2017
RADIOTHERAPY
PAPER ? |||
RTH/D/17/41/III
Time : 3 hours
Max. Marks : 100
lmgortant instructions:
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/?owcharts wherever appropriate.
Write short notes on:
1. a) Compare preoperative versus postoperative radiation 4+4+2
in locally advanced rectal cancer.
b)Compare long versus short course preoperative
radiotherapy in rectal cancer.
0) Radiotherapy versus chemoradiotherapy in rectal
cancer.
2. a) Initial diagnostic work up of a suspected multiple 4+3+3
myeloma
b) Mention major & minor diagnostic and prognostic
criteria.
0) Management of a solitary plasmacytoma.
3. a) What is the role of sealed and unsealed radionuclide 2+4+4
sources in cancer management?
b) Discuss different altered fractionation schemes and
their rationale.
c) What are the different types of immobilization devices
used in head and neck radiotherapy?
4. Write the rationale behind, giving examples: 3+3+4
a) Neoadjuvant chemotherapy followed by radiotherapy
b) Radiotherapy followed by adjuvant chemotherapy
c) Concurrent chemoradiotherapy
5. a) What is asymmetric collimation? 4+3+3
b) Use of wedges
c) Use of tissue compensators
6. Management of: 5+5
a) Superficial bladder cancer
b) Muscle invasive bladder cancer
.1.
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2017
7. Role of: 3+4+3
a) EBRT in carcinoma oesophagus
b) Chemoradiotherapy in carcinoma oesophagus
c) Brachytherapy in carcinoma oesophagus
8. Integration of molecular targeted approaches with 3+3+4
radiotherapy:
a) Give examples
b) Rationale
0) Clinical trials
9. a) What is the purpose of IGRT? In what way it differs 4+3+3
from 2?D RT, 3?D CRT and IMRT?
b) Describe different methods of imaging techniques used
for IGRT.
c) KV versus MV imaging.
10. a)Current status of neoadjuvant chemotherapy in 3+3+4
carcinoma cervix.
b) What is radical trachelectomy?
c)What basic fundamentals should be taken into
consideration while planning a patient for
radiotherapy?
.2.
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.